Table 1.
Age-adjusted mortality rates of haematological cancers in Spain (per 100,000 European standard population) by sex and 5-year calendar period
| |
1952–1956 |
1957–1961 |
1962–1966 |
1967–1971 |
1972–1976 |
1977–1981 |
1982–1986 |
1987–1991 |
1992–1996 |
1997–2001 |
2002–2006 |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Haematological cancer | No. of deaths | Rate | No. of deaths | Rate | No. of deaths | Rate | No. of deaths | Rate | No. of deaths | Rate | No. of deaths | Rate | No. of deaths | Rate | No. of deaths | Rate | No. of deaths | Rate | No. of deaths | Rate | No. of deaths | Rate |
|
Hodgkin’s disease |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Men |
659 |
1.13 |
894 |
1.45 |
1,091 |
1.65 |
1,214 |
1.73 |
1,201 |
1.63 |
1,052 |
1.32 |
982 |
1.14 |
951 |
1.03 |
794 |
0.80 |
698 |
0.63 |
647 |
0.52 |
| Women |
406 |
0.61 |
510 |
0.72 |
624 |
0.82 |
642 |
0.80 |
633 |
0.75 |
625 |
0.66 |
614 |
0.60 |
583 |
0.51 |
592 |
0.46 |
538 |
0.39 |
496 |
0.31 |
| Male-to-female ratio1 (95% CI) |
|
1.84 (1.62–2.09) |
|
2.01 (1.80–2.24) |
|
2.01 (1.82–2.22) |
|
2.17 (1.97–2.39) |
|
2.17 (1.97–2.40) |
|
1.98 (1.80–2.19) |
|
1.92 (1.73–2.12) |
|
2.03 (1.82–2.25) |
|
1.73 (1.55–1.93) |
|
1.65 (1.46–1.85) |
|
1.67 (1.48–1.89) |
|
Non-Hodgkin’s lymphoma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
| Men |
360 |
0.65 |
554 |
0.93 |
875 |
1.36 |
1,098 |
1.55 |
1,540 |
2.07 |
1,982 |
2.47 |
2,736 |
3.19 |
3,992 |
4.30 |
5,046 |
5.00 |
5,957 |
5.29 |
6,272 |
4.97 |
| Women |
232 |
0.36 |
295 |
0.42 |
555 |
0.74 |
660 |
0.81 |
972 |
1.12 |
1,369 |
1.43 |
2,022 |
1.85 |
3,226 |
2.70 |
4,394 |
3.25 |
5,457 |
3.58 |
5,652 |
3.21 |
| Male-to-female ratio1 (95% CI) |
|
1.82 (1.54–2.16) |
|
2.20 (1.90–2.54) |
|
1.84 (1.65–2.05) |
|
1.91 (1.73–2.11) |
|
1.85 (1.71–2.01) |
|
1.72 (1.61–1.85) |
|
1.72 (1.62–1.82) |
|
1.59 (1.52–1.67) |
|
1.54 (1.47–1.60) |
|
1.48 (1.42–1.54) |
|
1.55 (1.49–1.61) |
|
Multiple myeloma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Men |
|
|
|
|
215 |
0.37 |
290 |
0.46 |
679 |
1.01 |
1,132 |
1.52 |
1,731 |
2.06 |
2,351 |
2.51 |
2,949 |
2.87 |
3,660 |
3.13 |
3,881 |
2.90 |
| Women |
|
|
|
|
197 |
0.27 |
294 |
0.37 |
683 |
0.78 |
1,145 |
1.16 |
1,642 |
1.44 |
2,311 |
1.81 |
2,984 |
2.09 |
3,717 |
2.27 |
3,920 |
2.11 |
| Male-to-female ratio1 (95% CI) |
|
|
|
|
|
1.35 (1.11–1.64) |
|
1.22 (1.04–1.44) |
|
1.30 (1.16–1.44) |
|
1.30 (1.20–1.42) |
|
1.43 (1.33–1.53) |
|
1.39 (1.31–1.47) |
|
1.37 (1.30–1.45) |
|
1.38 (1.31–1.44) |
|
1.38 (1.31–1.44) |
|
Leukaemia |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Men |
1,592 |
2.63 |
2,435 |
3.77 |
3,128 |
4.50 |
3,648 |
4.93 |
4,224 |
5.56 |
4,927 |
6.06 |
5,881 |
6.75 |
6,562 |
7.03 |
7,132 |
7.03 |
7,748 |
6.86 |
8,547 |
6.67 |
| Women |
1,338 |
1.94 |
2,097 |
2.82 |
2,778 |
3.55 |
3,073 |
3.67 |
3,576 |
4.01 |
4,109 |
4.21 |
4,630 |
4.27 |
5,316 |
4.45 |
5,674 |
4.27 |
6,166 |
4.12 |
6,609 |
3.81 |
| Male-to-female ratio1 (95% CI) | 1.36 (1.26–1.46) | 1.33 (1.26–1.42) | 1.27 (1.20–1.33) | 1.34 (1.28–1.41) | 1.39 (1.32–1.45) | 1.44 (1.38–1.50) | 1.58 (1.52–1.64) | 1.58 (1.52–1.64) | 1.65 (1.59–1.71) | 1.67 (1.61–1.73) | 1.75 (1.69–1.81) | |||||||||||
1Age-adjusted mortality rate ratio of males to females and 95% confidence interval (CI).